Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Myriad Genetics, |
RCV002306501 | SCV002602528 | likely pathogenic | Ellis-van Creveld syndrome | 2022-01-15 | criteria provided, single submitter | clinical testing | NM_147127.4(EVC2):c.3459_3460delTC(Q1154Afs*18) is expected to be pathogenic in the context of EVC2-related Ellis-van Creveld syndrome. This variant is predicted to lead to an abnormal or absent protein product due to the creation of a premature termination codon in EVC2, a gene where loss-of-function variants are known to be pathogenic. Please note: this variant was assessed in the context of healthy population screening. |